← Eichor
Study identifier: NCT06490809 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Minimal Clinically Important Difference of the Box and Block Test in Parkinson

Condition: Parkinson Disease  ·  Sponsor: Emre Şenocak

PhaseNA
Planned participants44
Who can joinAll sexes, 50 Years to 80 Years
Healthy volunteersNo

About this study

The aim of this study is to examine the level of clinical change in gross manual skills of Parkinson's patients who receive conventional physiotherapy. For this purpose, the Box-Block Test will be used, and the amount of change that must occur in the patient's hand functions will be determined for the test to be considered clinically meaningful. Patients will continue their routine physical therapy sessions and the researchers will not interfere with this program. The treatment program will be created by the clinical specialist physician and physiotherapist. Upper extremity rehabilitation programs for Parkinson's patients generally consist of methods such as stretching, strengthening, reaching, coordination and recreational activities. Patients will receive physiotherapy for 30 sessions.

This description comes directly from the study's public registry record.

Talk to the study team

Emre Şenocak, PhD  ·  +90 553 569 56 92  ·  emre.senocak@windowslive.com

Always discuss trial participation with your own doctor first.

Locations (1)

Özel Öz İstanbul Tıp MerkeziIstanbul, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06490809